Clinical Trial Update: T Cell Therapy of Opportunistic Cytomegalovirus Infection [EARLY_Phase 1]

View source ↗

Summary

This early-phase clinical trial is evaluating T-cell therapy for opportunistic Cytomegalovirus infection in hematopoietic stem cell transplant recipients and is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections

Drugs mentioned

• CMV-specific T cell therapy (CMV-specific T cells)

Snippet

Sponsor: Mari Dallas | Conditions: Cytomegalovirus Infections, Hematopoietic Stem Cell Transplant | EARLY_Phase 1 | Status: RECRUITING